SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-266453"
 

Search: onr:"swepub:oai:DiVA.org:uu-266453" > Managing synchronou...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Adam, René (author)

Managing synchronous liver metastases from colorectal cancer : A multidisciplinary international consensus

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • Elsevier BV,2015
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-266453
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-266453URI
  • https://doi.org/10.1016/j.ctrv.2015.06.006DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • An international panel of multidisciplinary experts convened to develop recommendations for managing patients with colorectal cancer (CRC) and synchronous liver metastases (CRCLM). A modified Delphi method was used. CRCLM is defined as liver metastases detected at or before diagnosis of the primary CRC. Early and late metachronous metastases are defined as those detected ⩽12months and >12months after surgery, respectively. To provide information on potential curability, use of high-quality contrast-enhanced computed tomography (CT) before chemotherapy is recommended. Magnetic resonance imaging is increasingly being used preoperatively to aid detection of subcentimetric metastases, and alongside CT in difficult situations. To evaluate operability, radiology should provide information on: nodule size and number, segmental localization and relationship with major vessels, response after neoadjuvant chemotherapy, non-tumoral liver condition and anticipated remnant liver volume. Pathological evaluation should assess response to preoperative chemotherapy for both the primary tumour and metastases, and provide information on the tumour, margin size and micrometastases. Although the treatment strategy depends on the clinical scenario, the consensus was for chemotherapy before surgery in most cases. When the primary CRC is asymptomatic, liver surgery may be performed first (reverse approach). When CRCLM are unresectable, the goal of preoperative chemotherapy is to downsize tumours to allow resection. Hepatic resection should not be denied to patients with stable disease after optimal chemotherapy, provided an adequate liver remnant with inflow and outflow preservation remains. All patients with synchronous CRCLM should be evaluated by a hepatobiliary multidisciplinary team.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • de Gramont, Aimery (author)
  • Figueras, Joan (author)
  • Kokudo, Norihiro (author)
  • Kunstlinger, Francis (author)
  • Loyer, Evelyne (author)
  • Poston, Graeme (author)
  • Rougier, Philippe (author)
  • Rubbia-Brandt, Laura (author)
  • Sobrero, Alberto (author)
  • Teh, Catherine (author)
  • Tejpar, Sabine (author)
  • Van Cutsem, Eric (author)
  • Vauthey, Jean-Nicolas (author)
  • Påhlman, LarsUppsala universitet,Kolorektalkirurgi(Swepub:uu)larspahl (author)
  • Uppsala universitetKolorektalkirurgi (creator_code:org_t)

Related titles

  • In:Cancer Treatment Reviews: Elsevier BV41:9, s. 729-7410305-73721532-1967

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view